Pi Financial lowered shares of Aurora Cannabis (TSE:ACB) from a buy rating to a neutral rating in a report issued on Monday, BayStreet.CA reports. Pi Financial currently has C$2.00 price target on the stock, down from their prior price target of C$6.00.

Other equities analysts have also issued reports about the stock. AltaCorp Capital reissued a sector perform rating on shares of Aurora Cannabis in a research report on Wednesday, December 18th. Jefferies Financial Group lowered shares of Aurora Cannabis from a buy rating to a hold rating and reduced their price target for the stock from C$7.00 to C$3.00 in a research report on Tuesday, December 24th. Stifel Nicolaus reduced their price target on shares of Aurora Cannabis from C$1.75 to C$1.00 in a research report on Friday, February 7th. Canaccord Genuity lowered shares of Aurora Cannabis from a speculative buy rating to a hold rating and reduced their price target for the stock from C$6.00 to C$3.00 in a research report on Friday, February 7th. Finally, Laurentian set a C$4.75 price target on shares of Aurora Cannabis and gave the stock a buy rating in a research report on Tuesday, December 17th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and five have assigned a buy rating to the stock. The company has an average rating of Hold and a consensus price target of C$6.13.

ACB opened at C$1.96 on Monday. Aurora Cannabis has a 12-month low of C$1.90 and a 12-month high of C$13.67. The company has a current ratio of 1.27, a quick ratio of 0.63 and a debt-to-equity ratio of 17.82. The firm has a market capitalization of $2.53 billion and a PE ratio of -5.36. The firm has a 50 day moving average of C$2.50 and a two-hundred day moving average of C$4.89.

Aurora Cannabis (TSE:ACB) last posted its quarterly earnings results on Thursday, November 14th. The company reported C$0.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of C($0.04) by C$0.05. The business had revenue of C$75.25 million for the quarter, compared to analysts’ expectations of C$95.87 million. As a group, analysts predict that Aurora Cannabis will post -0.15 EPS for the current fiscal year.

About Aurora Cannabis

Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.

Featured Story: Penny Stocks

Analyst Recommendations for Aurora Cannabis (TSE:ACB)

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.